Literature DB >> 27878852

Optimal design of longitudinal data analysis using generalized estimating equation models.

Jingxia Liu1, Graham A Colditz2.   

Abstract

Longitudinal studies are often applied in biomedical research and clinical trials to evaluate the treatment effect. The association pattern within the subject must be considered in both sample size calculation and the analysis. One of the most important approaches to analyze such a study is the generalized estimating equation (GEE) proposed by Liang and Zeger, in which "working correlation structure" is introduced and the association pattern within the subject depends on a vector of association parameters denoted by ρ. The explicit sample size formulas for two-group comparison in linear and logistic regression models are obtained based on the GEE method by Liu and Liang. For cluster randomized trials (CRTs), researchers proposed the optimal sample sizes at both the cluster and individual level as a function of sampling costs and the intracluster correlation coefficient (ICC). In these approaches, the optimal sample sizes depend strongly on the ICC. However, the ICC is usually unknown for CRTs and multicenter trials. To overcome this shortcoming, Van Breukelen et al. consider a range of possible ICC values identified from literature reviews and present Maximin designs (MMDs) based on relative efficiency (RE) and efficiency under budget and cost constraints. In this paper, the optimal sample size and number of repeated measurements using GEE models with an exchangeable working correlation matrix is proposed under the considerations of fixed budget, where "optimal" refers to maximum power for a given sampling budget. The equations of sample size and number of repeated measurements for a known parameter value ρ are derived and a straightforward algorithm for unknown ρ is developed. Applications in practice are discussed. We also discuss the existence of the optimal design when an AR(1) working correlation matrix is assumed. Our proposed method can be extended under the scenarios when the true and working correlation matrix are different.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Generalized estimating equation; Longitudinal studies; Optimal design; Power; Working correlation matrix

Mesh:

Year:  2016        PMID: 27878852      PMCID: PMC5575779          DOI: 10.1002/bimj.201600107

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  30 in total

1.  Analysis of cluster randomized trials in primary care: a practical approach.

Authors:  M K Campbell; J Mollison; N Steen; J M Grimshaw; M Eccles
Journal:  Fam Pract       Date:  2000-04       Impact factor: 2.267

2.  Efficient design of cluster randomized and multicentre trials with unknown intraclass correlation.

Authors:  Gerard J P van Breukelen; Math J J M Candel
Journal:  Stat Methods Med Res       Date:  2011-09-20       Impact factor: 3.021

Review 3.  Balancing the number and size of sites: an economic approach to the optimal design of cluster samples.

Authors:  Luke B Connelly
Journal:  Control Clin Trials       Date:  2003-10

4.  Sample size calculations for controlled clinical trials using generalized estimating equations (GEE).

Authors:  G Dahmen; J Rochon; I R König; A Ziegler
Journal:  Methods Inf Med       Date:  2004       Impact factor: 2.176

5.  Robustness of optimal design of fMRI experiments with application of a genetic algorithm.

Authors:  Bärbel Maus; Gerard J P van Breukelen; Rainer Goebel; Martijn P F Berger
Journal:  Neuroimage       Date:  2009-10-13       Impact factor: 6.556

6.  Estimation and sample size considerations for clustered binary responses.

Authors:  E W Lee; N Dubin
Journal:  Stat Med       Date:  1994-06-30       Impact factor: 2.373

7.  Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance.

Authors:  Chun Chieh Lin; Suanna S Bruinooge; M Kelsey Kirkwood; Christine Olsen; Ahmedin Jemal; Dean Bajorin; Sharon H Giordano; Michael Goldstein; B Ashleigh Guadagnolo; Michael Kosty; Shane Hopkins; James B Yu; Anna Arnone; Amy Hanley; Stephanie Stevens; Dawn L Hershman
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

8.  Incorporation of clustering effects for the Wilcoxon rank sum test: a large-sample approach.

Authors:  Bernard Rosner; Robert J Glynn; Mei-Ling Ting Lee
Journal:  Biometrics       Date:  2003-12       Impact factor: 2.571

9.  Reduction of self-perceived discomforts in critically ill patients in French intensive care units: study protocol for a cluster-randomized controlled trial.

Authors:  Pierre Kalfon; Olivier Mimoz; Anderson Loundou; Marie-Agnès Geantot; Nathalie Revel; Isabelle Villard; Julien Amour; Elie Azoulay; Maïté Garrouste-Orgeas; Claude Martin; Tarek Sharshar; Karine Baumstarck; Pascal Auquier
Journal:  Trials       Date:  2016-02-16       Impact factor: 2.279

10.  Effect of Behavior Modification on Outcome in Early- to Moderate-Stage Chronic Kidney Disease: A Cluster-Randomized Trial.

Authors:  Kunihiro Yamagata; Hirofumi Makino; Kunitoshi Iseki; Sadayoshi Ito; Kenjiro Kimura; Eiji Kusano; Takanori Shibata; Kimio Tomita; Ichiei Narita; Tomoya Nishino; Yoshihide Fujigaki; Tetsuya Mitarai; Tsuyoshi Watanabe; Takashi Wada; Teiji Nakamura; Seiichi Matsuo
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

View more
  6 in total

1.  Optimal designs in three-level cluster randomized trials with a binary outcome.

Authors:  Jingxia Liu; Lei Liu; Graham A Colditz
Journal:  Stat Med       Date:  2019-06-04       Impact factor: 2.373

2.  Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.

Authors:  Nicholas A Kolaitis; Roham T Zamanian; Vinicio A de Jesus Perez; David B Badesch; Raymond L Benza; Charles D Burger; Murali M Chakinala; Jean M Elwing; Jeremy Feldman; Matthew R Lammi; Stephen C Mathai; John W McConnell; Kenneth W Presberg; Jeffrey C Robinson; Jeffrey Sager; Oksana A Shlobin; Marc A Simon; Steven M Kawut; David V Glidden; Jonathan P Singer; Teresa De Marco
Journal:  Ann Am Thorac Soc       Date:  2021-04

3.  The correlation between longitudinal changes in hypothalamic-pituitary-adrenal (HPA)-axis activity and changes in neurocognitive function in mixed-state bipolar II disorder.

Authors:  Hsuan-Han Lee; Cheng-Ho Chang; Liang-Jen Wang; Chih-Ching Wu; Hsing-Ling Chen; Ti Lu; Ru-Band Lu; Sheng-Yu Lee
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-15       Impact factor: 2.570

4.  Catastrophic health expenditure among Chinese adults living alone with cognitive impairment: findings from the CHARLS.

Authors:  Chenxi Li; Shuyi Jin; Xingqi Cao; Ling Han; Ning Sun; Heather Allore; Emiel O Hoogendijk; Xin Xu; Qiushi Feng; Xiaoting Liu; Zuyun Liu
Journal:  BMC Geriatr       Date:  2022-08-04       Impact factor: 4.070

5.  Efficacy and Renal Safety of Prophylactic Tenofovir Alafenamide for HBV-Infected Cancer Patients Undergoing Chemotherapy.

Authors:  I-Cheng Lee; Keng-Hsin Lan; Chien-Wei Su; Chung-Pin Li; Yee Chao; Han-Chieh Lin; Ming-Chih Hou; Yi-Hsiang Huang
Journal:  Int J Mol Sci       Date:  2022-09-26       Impact factor: 6.208

6.  The analgesic efficacy of anterior femoral cutaneous nerve block in combination with femoral triangle block in total knee arthroplasty: a randomized controlled trial.

Authors:  Wirinaree Kampitak; Aree Tanavalee; Tanvaa Tansatit; Srihatach Ngarmukos; Nattaporn Songborassamee; Chutikant Vichainarong
Journal:  Korean J Anesthesiol       Date:  2021-06-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.